Released on 2026-02-13

DPP_UC_immunophenotypes

Accession number
ELU-2-2F8A73-1
Description
Ulcerative Colitis immunophenotyping dataset from the ImmUniverse DPP Cohort (AD/UC)

Version
V1.0
Created on
-
Updated on
-
Data types
Methylation_array RNASeq MicroRNA_array Samples Other_omics_data Proteomics Metabolomics Clinical_data Metagenomics
Type of Samples Collected
Blood
Number of Samples Collected
75
Treatment or experiment categories
Flow-cytometry immunophenotyping
Data owner
-
Main contact
Hans Koenen
Email
hans.koenen@radboudumc.nl
Affiliation
Radboudumc

thumb_up Permissions

Use Condition Remarks Category (GA4GH)
Use is not limited to a specific research/disease area. Limited scope of research. Is data consented to be used only in specific research/disease areas? E.g. use only in Biomedical Research. Other Research-specific restrictions (RS)
Consent does not contain clauses of geographical restrictions. Geographical restriction. Does consent contain clauses that put geographical restrictions to the sharing of data? E.g. not to be shared outside Country A, B, or EU/EEA. Geographical Restrictions (GS)
Data can be used for other purposes than Research Use (see Consortium Agreement for more detail). - Does the limitation to the RESEARCH PROJECT include the RESEARCH USE (as defined in the Consortium Agreement)? Project-Specific restrictions (PS)
There is no requirement to return data. Data return requirements Is there a requirement to return data or documents to the database/resource? Return data to database/resource (RTN)
No Are there any Intellectual Property (IP) restrictions/requirements when using the DATA? IP claim terms (IP)

info Constrained permissions

Use Condition Remarks Category (GA4GH)
Yes – Only to ImmUniverse consortium institutions that signed the DSA Restricted type of recipients. Does the consent limit the type of recipients? E.g. data can be sent only to a specific type of institution such as private research institutions or public research institutions or to a named list of institutions. Institution-Specific restrictions (IS)
ImmUniverse Use of DATA is limited to the RESEARCH PROJECT. Is the use of data limited to the project named in the Submission sheet? Project-Specific restrictions (PS)
All ImmUniverse Beneficiaries that signed the DSA: HUNIMED, AIT, ISS, CAU, UCAM, AMC, VIB, KU Leuven, LMU, AU, AUH, UNILU, JRF, RUMC, CHRU, ITTM, GSK, Sanofi, Lilly, Novartis, Pfizer User specific restrictions Is the use limited to approved users/groups/institutions? User-Specific restrictions (US)

hardware Obligations

Use Condition Remarks Category (GA4GH)
Yes – Until July 2026 unless extended under consortium agreement Retention time. Does the consent contain clauses that put time-limits on the use of data? Time Limits on use (TS)
Publications must acknowledge the ImmUniverse project and relevant cohorts Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study. Publication Required (PUB)